NEXGEL, INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
NXGL$3.58-1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
NEXGEL, INC
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS: | ||
| Current Assets: | ||
| Cash | $317 | $1,807 |
| Restricted cash | 741 | - |
| Accounts receivable, net | 673 | 933 |
| Inventory | 2,111 | 1,751 |
| Prepaid expenses and other current assets | 496 | 623 |
| Total current assets | 4,338 | 5,114 |
| Goodwill | 1,128 | 1,128 |
| Intangibles, net | 681 | 807 |
| Property and equipment, net | 1,955 | 2,211 |
| Operating lease - right of use asset | 2,015 | 1,628 |
| Investment in NexGelRx | 249 | - |
| Other assets | 95 | 95 |
| Total assets | $10,461 | $10,983 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities: | ||
| Accounts payable | $723 | $761 |
| Accounts payable – related party | 566 | 531 |
| Accrued expenses and other current liabilities | 460 | 310 |
| Deferred revenue | 2 | 179 |
| Current portion of note payable | 99 | 97 |
| Partnership accrued advance | 731 | - |
| Warrant liability and contingent consideration liability | - | 296 |
| Current portion of finance lease liability | 65 | 59 |
| Current portion of operating lease liability | 310 | 237 |
| Total current liabilities | 2,956 | 2,470 |
| Operating lease liability, net of current portion | 1,883 | 1,538 |
| Finance lease liability, net of current portion | 242 | 307 |
| Notes payable, net of current portion | 489 | 588 |
| Total liabilities | 5,570 | 4,903 |
| Commitments and Contingencies (Note 18) | - | - |
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock, par value $0.001 per share, 5,000,000 shares authorized, no shares issued and outstanding | - | - |
| Common stock, par value $0.001 per share, 25,000,000 shares authorized; 8,143,133 and 7,638,497 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 8 | 8 |
| Additional paid-in capital | 25,447 | 23,743 |
| Accumulated deficit | (20,996) | (17,996) |
| Total NexGel stockholders’ equity | 4,459 | 5,755 |
| Non-controlling interest in joint venture | 432 | 325 |
| Total stockholders’ equity | 4,891 | 6,080 |
| Total liabilities and stockholders’ equity | $10,461 | $10,983 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.